The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM
Ian McGowan(University of Pittsburgh), Roy M. Gulick(New York University), Rhonda M. Brand(University of Pittsburgh), Kenneth H. Mayer(Miriam Hospital), Ross Cranston(Universitat de Barcelona), Jason E. Farley(Johns Hopkins University), Raphael J. Landovitz(APLA Health), Adriana Andrade(Johns Hopkins University), Marybeth McCauley(Family Health International 360), Craig W. Hendrix(Unknown), Peter A. Anton(University of California, Los Angeles), Peter L. Anderson(University of Colorado Denver), Wairimu Chege(National Institutes of Health), Susan H. Eshleman(Johns Hopkins University), Mark A. Marzinke(Family Health International 360), Ying Chen(Shandong University of Traditional Chinese Medicine), Chunyuan Wu, Paul Richardson(Johns Hopkins University), Timothy Wilkin(Cornell University)
Cited by 19
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k